RESUMEN
Objective: To assess the resilience and staging degree relating to sociodemographic factors of breast cancer survivors followed up in an oncology service. Method: Quantitative study with 112 breast cancer survivors.The variables selected were: sociodemographic; clinical staging; survival time; and resilience scale. The analysis was performed using the Epi Info 6.04 software and Fishers exact test. The research was approved by the Ethics Committee of the Federal University of Pelotas School of Nursing under Opinion Nº 31/2009. Results: The average age was 46.2 years, there was 60.71% of stage IIcases, 81.25% were white, 40.18% had five-to eight-year schooling, 52.68% were married, 73.32% had lived in urban areas, 41.96% exhibited high resilience, and 48.21% were followed up from one to three years. Conclusion: Staging was not associated with the resilience degree, but rather with age and survival time, confirming the findings of other studies.
Objetivo: Investigar o grau de resiliência e de estadiamento frente aos fatores sociodemográficos dos sobreviventes ao câncer de mama em acompanhamento em um serviço de oncologia. Método: Estudo quantitativo com amostra de 112 sobreviventes ao câncer de mama. Foram selecionadas variáveis sociodemográficas, estadiamento clínico, tempo de sobrevida e escala de resiliência. A análise foi realizada utilizando o software Epi Info 6.04 e o teste exato de Fisher. A pesquisa foi aprovada pelo Comitê de Ética da Faculdade de Enfermagem da Universidade Federal de Pelotas sob o Parecer nº 31/2009. Resultados: A média de idade foi de 46,2 anos, houve 60,71% de estadiamento II, 81,25% eram brancos,40,18% tinham escolaridade entre cinco e oito anos, 52,68% eram casados,73,32% havia vivido em zona urbana, 41,96% apresentou alta resiliência e 48,21% mantinha-se em acompanhamento entre um e três anos.Conclusão: O estadiamento não esteve associado ao grau de resiliência,mas sim à idade e tempo de sobrevida, confirmando os achados em outros estudos.
Objetivo: Investigar el grado de resiliencia y estadificación en relación con factores sociodemográficos de sobrevivientes de cáncer de mama en seguimiento en un servicio de oncología. Método: Estudio cuantitativo con 112 sobrevivientes de cáncer de mama. Las variables seleccionadas fueron: sociodemográficas; estadificación clínica; tiempo de sobrevida; y escala de resistencia. El análisis se realizó utilizando el software EpiInfo 6.04 y el test exacto de Fisher. La investigación fue aprobada por el Comité de Ética de la Facultad de Enfermería de la Universidad Federal de Pelotas con el Dictamen Nº 31/2009. Resultados: La edad promedio fue de 46,2 años, 60.71% estaban en estadio II, 81.25% eran blancos, 40.18% tenían escolaridad entre cinco y ocho años, 52.68% eran casados, 73.32% habían vivido en zonas urbanas, 41.96% tuvieron alta resiliencia y el 48,21% estaban en seguimiento entre uno y tres años. Conclusión: La estadificación no estuvo asociada al grado de resiliencia, sino a la edad y tiempo de sobrevida, confirmando los hallazgos de otros estudios.
Asunto(s)
Humanos , Masculino , Femenino , Estadificación de Neoplasias/psicología , Neoplasias de la Mama/mortalidad , Resiliencia Psicológica , BrasilRESUMEN
The aim of this cross-sectional study is to investigate demographic and clinical factors that interfere with quality of life (QoL) in women with breast cancer. The sample was composed of 73 women at the mean age of 47.8 (sd=7.8) years and time of disease at 3.08 (sd=3.2) years. For purposes of assessing QoL, we applied the WHOQOL-bref instrument and for detecting depressive symptoms, the Beck Depression Inventory (BDI). Because variables were arranged into temporally related categories, hierarchical multiple linear regression was performed: Group 1 (age and educational background), Group 2 (staging, time of disease, mastectomy and chemotherapy) and Group 3 (BDI). The lowest QoL ratings were associated with mastectomy in the physical (p=0.002) and psychological (p=0.02) domains and depressive symptoms in all domains of WHOQOL-bref (p<0.05). Because QoL assessments are viewed as potentially useful in clinical practice, it is critical that health professionals be alert to patients' depressive symptoms even several years after cancer diagnosis.